# EDGAR Filing Document

**Accession Number:** 0000059478
**File Stem:** 0000059478-25-000256
**Filing Date:** 2025-11
**Character Count:** 5030
**Document Hash:** 6ea83edb25503a80a6cf7dc02e1eee45
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000059478-25-000256.hdr.sgml**: 20251114

**ACCESSION NUMBER**: 0000059478-25-000256

**CONFORMED SUBMISSION TYPE**: 3

**PUBLIC DOCUMENT COUNT**: 5

**CONFORMED PERIOD OF REPORT**: 20251107

**FILED AS OF DATE**: 20251114

**DATE AS OF CHANGE**: 20251114

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Brown Adrienne S
- **CENTRAL INDEX KEY:** 0002096888

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 3
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-06351
- **FILM NUMBER:** 251486243

**MAIL ADDRESS:**
- **STREET 1:** C/O ELI LILLY AND COMPANY
- **STREET 2:** 893 S DELAWARE STREET
- **CITY:** INDIANAPOLIS
- **STATE:** IN
- **ZIP:** 46225
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** ELI LILLY & Co
- **CENTRAL INDEX KEY:** 0000059478
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 350470950
- **STATE OF INCORPORATION:** IN
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** LILLY CORPORATE CTR
- **STREET 2:** DROP CODE 1094
- **CITY:** INDIANAPOLIS
- **STATE:** IN
- **ZIP:** 46285
- **BUSINESS PHONE:** 3172762000

**MAIL ADDRESS:**
- **STREET 1:** LILLY CORPORATE CENTER
- **STREET 2:** DROP CODE 1094
- **CITY:** INDIANAPOLIS
- **STATE:** IN
- **ZIP:** 46285

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** LILLY ELI & CO
- **DATE OF NAME CHANGE:** 19941024

## Ex-24

![](adriennebrownpoa001.jpg)

------

![](adriennebrownpoa002.jpg)

------

![](adriennebrownpoa003.jpg)

------

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 3

### INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Brown Adrienne S<br><sub>(Last) (First) (Middle)</sub><br>LILLY CORPORATE CENTER<br><sub>(Street)</sub><br>INDIANAPOLIS, IN 46285<br><sub>(City) (State) (Zip)</sub> | **3. Issuer Name and Ticker or Trading Symbol**<br>ELI LILLY & Co [ LLY ] | **5. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  |
| **2. Date of Event Requiring Statement (Month/Day/Year)**<br>2025-11-07 | **4. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director   [ ] 10% Owner<br>[X] Officer (give title below)   [ ] Other (specify below)<br>_EVP,  President LLY Imm_ | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities Beneficially Owned

---

|  |  |  |  |
| --- | --- | --- | --- |
| 1. Title of Security | 2. Amount of Securities Beneficially Owned | 3. Ownership Form | 4. Nature of Indirect Beneficial Ownership |
| Common Stock | 3725 | D |  |

---

## Table II - Derivative Securities Beneficially Owned

---

|  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Underlying Securities | 3. Title and Amount of Underlying Securities | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| Restricted Stock Unit | 2026-02-16 | 2026-02-16 | Common Stock | 391 | <sup>(1)</sup> | D |  |
| Restricted Stock Unit | 2026-11-01 | 2026-11-01 | Common Stock | 2530 | <sup>(1)</sup> | D |  |
| Restricted Stock Unit | 2027-02-16 | 2027-02-16 | Common Stock | 394 | <sup>(1)</sup> | D |  |
| Restricted Stock Unit | 2028-02-16 | 2028-02-16 | Common Stock | 354.091 | <sup>(1)</sup> | D |  |

---

### Footnotes:

(1) Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.

**Remarks:**
Exhibit 24 - Power of Attorney

**Signature:** /s/ Jonathan Groff for Adrienne Brown, pursuant to authorization attached  
**Date:** 2025-11-14

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**